Skip to main content
iNtRON Biotechnology, Inc. logo

iNtRON Biotechnology, Inc. — Investor Relations & Filings

Ticker · 048530 ISIN · KR7048530000 KO Manufacturing
Open in API
Filings indexed 268 across all filing types
Latest filing 2020-05-19 Regulatory Filings
Country KR South Korea
Listing KO 048530

About iNtRON Biotechnology, Inc.

https://intronbio.com:6001

iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Intron Biotechnology. It details the contract value, counterparty, duration, and terms. Since this is a specific regulatory announcement of a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-05-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically by '파이안제3호 유한회사' in '인트론바이오테크놀로지'), including acquisition/disposal methods and shareholding percentages. This falls under the category of Major Shareholding Notification.
2020-05-18 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 인트론바이오테크놀로지' covering the period from 2020-01-01 to 2020-03-31. It contains detailed financial information, business descriptions, and management disclosures typical of a formal quarterly filing. It is not a short announcement or a certification, but the full report itself. Q1 2020
2020-05-15 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from Intron Biotechnology regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, and terms. Since this is a specific regulatory disclosure of a material business event that does not fit into the other specialized categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2020-05-12 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Intron Biotechnology. It details the contract value, the counterparty (Osang Healthcare), the contract period, and the nature of the supply (molecular diagnostic reagent raw materials). This type of disclosure is a standard regulatory filing in the Korean market (DART system) for material business contracts, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or capital changes.
2020-04-22 Korean
주권매매거래정지(단일판매공급계약)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the temporary suspension of stock trading for Intron Biotechnology due to a single sales supply contract. It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding market operations and does not fit into specific categories like M&A or financial reporting, it falls under the general regulatory filings category.
2020-04-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.